These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
374 related articles for article (PubMed ID: 26651986)
21. Null hypothesis significance testing and effect sizes: can we 'effect' everything … or … anything? Lovell DP Curr Opin Pharmacol; 2020 Apr; 51():68-77. PubMed ID: 31948894 [TBL] [Abstract][Full Text] [Related]
22. To P or Not to P: Backing Bayesian Statistics. Buchinsky FJ; Chadha NK Otolaryngol Head Neck Surg; 2017 Dec; 157(6):915-918. PubMed ID: 29192853 [TBL] [Abstract][Full Text] [Related]
23. Unscaled Bayes factors for multiple hypothesis testing in microarray experiments. Bertolino F; Cabras S; Castellanos ME; Racugno W Stat Methods Med Res; 2015 Dec; 24(6):1030-43. PubMed ID: 22337766 [TBL] [Abstract][Full Text] [Related]
24. Waldian t tests: Sequential Bayesian t tests with controlled error probabilities. Schnuerch M; Heck DW; Erdfelder E Psychol Methods; 2024 Feb; 29(1):99-116. PubMed ID: 35420855 [TBL] [Abstract][Full Text] [Related]
25. Détente: A Practical Understanding of P values and Bayesian Posterior Probabilities. Ruberg SJ Clin Pharmacol Ther; 2021 Jun; 109(6):1489-1498. PubMed ID: 32748400 [TBL] [Abstract][Full Text] [Related]
27. Bayesian updating: increasing sample size during the course of a study. Moerbeek M BMC Med Res Methodol; 2021 Jul; 21(1):137. PubMed ID: 34225659 [TBL] [Abstract][Full Text] [Related]
28. Efficiency in sequential testing: Comparing the sequential probability ratio test and the sequential Bayes factor test. Stefan AM; Schönbrodt FD; Evans NJ; Wagenmakers EJ Behav Res Methods; 2022 Dec; 54(6):3100-3117. PubMed ID: 35233752 [TBL] [Abstract][Full Text] [Related]
29. An Introduction to Calculating Bayes Factors in JASP for Speech, Language, and Hearing Research. Brydges CR; Gaeta L J Speech Lang Hear Res; 2019 Dec; 62(12):4523-4533. PubMed ID: 31830850 [TBL] [Abstract][Full Text] [Related]
30. A Bayesian-frequentist two-stage single-arm phase II clinical trial design. Dong G; Shih WJ; Moore D; Quan H; Marcella S Stat Med; 2012 Aug; 31(19):2055-67. PubMed ID: 22415966 [TBL] [Abstract][Full Text] [Related]
32. A Bayesian sequential design with binary outcome. Zhu H; Yu Q; Mercante DE Pharm Stat; 2017 May; 16(3):192-200. PubMed ID: 28251815 [TBL] [Abstract][Full Text] [Related]
33. A tutorial on a practical Bayesian alternative to null-hypothesis significance testing. Masson ME Behav Res Methods; 2011 Sep; 43(3):679-90. PubMed ID: 21302025 [TBL] [Abstract][Full Text] [Related]
34. A Bayesian group sequential design for a multiple arm randomized clinical trial. Rosner GL; Berry DA Stat Med; 1995 Feb; 14(4):381-94. PubMed ID: 7746978 [TBL] [Abstract][Full Text] [Related]
35. Error Rates, Decisive Outcomes and Publication Bias with Several Inferential Methods. Hopkins WG; Batterham AM Sports Med; 2016 Oct; 46(10):1563-73. PubMed ID: 26971328 [TBL] [Abstract][Full Text] [Related]
36. Extracting a maximum of useful information from statistical research data. Sohlberg S; Andersson G Scand J Psychol; 2005 Feb; 46(1):69-77. PubMed ID: 15660635 [TBL] [Abstract][Full Text] [Related]
37. Reverse-Bayes analysis of two common misinterpretations of significance tests. Held L Clin Trials; 2013 Apr; 10(2):236-42. PubMed ID: 23329516 [TBL] [Abstract][Full Text] [Related]
38. How to Choose between Different Bayesian Posterior Indices for Hypothesis Testing in Practice. Kelter R Multivariate Behav Res; 2023; 58(1):160-188. PubMed ID: 34582284 [TBL] [Abstract][Full Text] [Related]
39. Things we still haven't learned (so far). Ivarsson A; Andersen MB; Stenling A; Johnson U; Lindwall M J Sport Exerc Psychol; 2015 Aug; 37(4):449-61. PubMed ID: 26442774 [TBL] [Abstract][Full Text] [Related]
40. The researcher and the consultant: from testing to probability statements. Hamra GB; Stang A; Poole C Eur J Epidemiol; 2015 Sep; 30(9):1003-8. PubMed ID: 26108655 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]